SELECTIVE-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUSES BY RACEMATES AND ENANTIOMERS OF CIS-5-FLUORO-1-[2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL]CYTOSINE

被引:268
作者
SCHINAZI, RF
MCMILLAN, A
CANNON, D
MATHIS, R
LLOYD, RM
PECK, A
SOMMADOSSI, JP
STCLAIR, M
WILSON, J
FURMAN, PA
PAINTER, G
CHOI, WB
LIOTTA, DC
机构
[1] EMORY UNIV,SCH MED,DEPT PEDIAT,BIOCHEM PHARMACOL LAB,ATLANTA,GA 30322
[2] EMORY UNIV,DEPT CHEM,ATLANTA,GA 30322
[3] UNIV ALABAMA,DEPT PHARMACOL,DIV CLIN PHARMACOL,CTR AIDS RES,BIRMINGHAM,AL 35294
[4] BURROUGHS WELLCOME CO,DIV VIROL,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1128/AAC.36.11.2423
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
2',3'-Dideoxy-5-fluoro-3'-thiacytidine (FTC) has been shown to be a potent and selective compound against human immunodeficiency virus type 1 in acutely infected primary human lymphocytes. FTC is also active against human immunodeficiency vims type 2, simian immunodeficiency virus, and feline immunodeficiency virus in various cell culture systems, including human monocytes. The antiviral activity can be prevented by 2'-deoxycytidine, but not by other natural nucleosides, suggesting that FTC must be phosphorylated to be active and 2'-deoxycytidine kinase is responsible for the phosphorylation. By using chiral columns or enzymatic techniques, the two enantiomers of FTC were separated. The (-)-beta-enantiomer of FTC was about 20-fold more potent than the (+)-beta-enantiomer against human immunodeficiency virus type 1 in peripheral blood mononuclear cells and was also effective in thymidine kinase-deficient CEM cells. Racemic FTC and its enantiomers were nontoxic to human lymphocytes and other cell lines at concentrations of up to 100 muM. Studies with human bone marrow cells indicated that racemic FTC and its (-)-enantiomer had a median inhibitory concentration of >30 muM. The (+)-enantiomer was significantly more toxic than the (-)-enantiomer to myeloid progenitor cells. The susceptibilities to FTC of pretherapy isolates in comparison with those of posttherapy 3'-azido-3'-deoxythymidine-resistant viruses in human lymphocytes were not substantially different. Similar results were obtained with well-defined 2',3'-dideoxyinosine- and nevirapine-resistant viruses. (-)-FTC-5'-triphosphate competitively inhibited human immunodeficiency virus type 1 reverse transcriptase, with an inhibition constant of 2.9 muM, when a poly(I)n . oligo(dC)19-24 template primer was used. A two- to threefold decreased affinity was noted for the (+)-enantiomer. By using sequencing analysis, racemic FTC-5'-triphosphate was shown to be a potent DNA chain terminator when human immunodeficiency vims reverse transcriptase was used. These results suggest that further development of the (-)-beta-enantiomer of FTC is warranted as an antiviral agent for infections caused by human immunodeficiency viruses.
引用
收藏
页码:2423 / 2431
页数:9
相关论文
共 48 条
  • [41] SHUGAR D, 1991, 3RD INT S MOL ASP CH, P239
  • [42] SOMMADOSSI JP, 1989, MOL PHARMACOL, V36, P9
  • [43] SOMMADOSSI JP, 1990, ANN NY ACAD SCI, V616, P356
  • [44] SOMMADOSSI JP, 1988, ANTIMICROG AGENTS CH, V7, P997
  • [45] ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY AND INVITRO TOXICITY OF 2'-DEOXY-3'-THIACYTIDINE (BCH-189), A NOVEL HETEROCYCLIC NUCLEOSIDE ANALOG
    SOUDEYNS, H
    YAO, XJ
    GAO, Q
    BELLEAU, B
    KRAUS, JL
    NGHE, NB
    SPIRA, B
    WAINBERG, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) : 1386 - 1390
  • [46] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE
    STCLAIR, MH
    MARTIN, JL
    TUDORWILLIAMS, G
    BACH, MC
    VAVRO, CL
    KING, DM
    KELLAM, P
    KEMP, SD
    LARDER, BA
    [J]. SCIENCE, 1991, 253 (5027) : 1557 - 1559
  • [47] INVITRO SCREENING FOR ANTIRETROVIRAL AGENTS AGAINST SIMIAN IMMUNODEFICIENCY VIRUS (SIV)
    TSAI, CC
    FOLLIS, KE
    YARNALL, M
    DEAVER, LE
    BENVENISTE, RE
    SAGER, PR
    [J]. ANTIVIRAL RESEARCH, 1990, 14 (02) : 87 - 98
  • [48] COMPARISON OF THE EFFECT OF CARBOVIR, AZT, AND DIDEOXYNUCLEOSIDE TRIPHOSPHATES ON THE ACTIVITY OF HUMAN IMMUNODEFICIENCY VIRUS REVERSE-TRANSCRIPTASE AND SELECTED HUMAN POLYMERASES
    WHITE, EL
    PARKER, WB
    MACY, LJ
    SHADDIX, SC
    MCCALEB, G
    SECRIST, JA
    VINCE, R
    SHANNON, WM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) : 393 - 398